Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

zerohedge.com - Tyler Durden - Big Pharma RINO Bill Cassidy Smoked By Trump-Endorsed Candidate In Louisiana Senate Primary
Big Pharma RINO Bill Cassidy Smoked By Trump-Endorsed Candidate In Louisiana Senate Primary
Zero Hedge

Senator Bill Cassidy (R-LA) came in third in Louisiana's Republican Senate primary on Saturday - marking the first time in nearly 15 years that a sitting US Senator has lost a primary in a regularly scheduled election. Instead, Trump-endorsed Rep.

fool.com - Jonathan Ponciano - Boxer Capital's $18 Million Corvus Pharma Bet Signals Confidence in This Biotech's Next Phase
Boxer Capital's $18 Million Corvus Pharma Bet Signals Confidence in This Biotech's Next Phase
The Motley Fool

On May 15, 2026, Boxer Capital Management disclosed a new position in Corvus Pharmaceuticals (CRVS 9.85%), acquiring 1,100,000 shares in the first quarter for an estimated $17.55 million based on quarterly average pricing. According to a May 15…

foreignpolicyjournal.com - Ewan Scott - Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Foreign Policy Journal

Income-focused investors in Vistin Pharma ASA (OB: VISTN) have a narrow window remaining to qualify for the Norwegian pharmaceutical company's next dividend payment. The ex-dividend date falls on May 22, meaning any investor who has not settled a…

statnews.com - Ed Silverman - U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
STAT

Two advocacy groups are demanding the United Kingdom revoke regulations at the heart of a new trade agreement with the U.S. over concerns the deal will allow outsiders to influence official decisions about the cost-effectiveness of medicines. And…

marketbeat.com - Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
MarketBeat

Commerzbank Aktiengesellschaft FI purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,417 shares of the biopharmaceutical…

marketbeat.com - Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
MarketBeat

Qsemble Capital Management LP acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 74,416…

indianexpress.com - Rahul Rao - Acutaas Chemicals: The specialty chemicals story the market is re-rating fast
Acutaas Chemicals: The specialty chemicals story the market is re-rating fast
The Indian Express

The key question is this: Is Acutaas Chemicals building a durable specialty chemicals franchise with multiple long-term growth engines? Or is the market extrapolating too much, too quickly, from a handful of high-growth verticals Understanding what…

thehindu.com - The Hindu Bureau - HRF alleges unchecked industrial effluent discharge in Anakapalli district
HRF alleges unchecked industrial effluent discharge in Anakapalli district
The Hindu

The Human Rights Forum (HRF) has alleged large-scale discharge of untreated and inadequately treated industrial effluents into water bodies in the Atchutapuram-Rambilli industrial corridor of Anakapalli district, and demanded immediate intervention…

minnpost.com - Matthew Blake - Pharmaceutical lobbyists can pop the champagne: Minnesota 340B legislation fails to get House vote on Legislature's final day to pass bills
Pharmaceutical lobbyists can pop the champagne: Minnesota 340B legislation fails to get House vote on Legislature's final day to pass bills
MinnPost

The pharmaceutical industry won. The hospital industry lost. After a lobbying fight for the ages between the Pharmaceutical Researchers and Manufacturers of America and the Minnesota Hospital Association over a mysterious prescription drug discount…

seekingalpha.com - Albert Anthony - Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

superpowers4good.com - Chandan Saha - The Great Capital Migration: What 5 Months of Closed Reg CF Campaigns Reveal About the Future of Impact Crowdfunding in 2026
The Great Capital Migration: What 5 Months of Closed Reg CF Campaigns Reveal About the Future of Impact Crowdfunding in 2026
Superpowers for Good

You can advertise in Superpowers for Good. Click to learn more about our affordable options. Over the past five months, the Regulation Impact Crowdfunding ecosystem has demonstrated remarkable resilience and evolution. As we analyze the data from…

247wallst.com - Omor Ibne Ehsan - One Low-Cost ETF For Europe, Japan, And A Lot Of Stocks Americans Ignore
One Low-Cost ETF For Europe, Japan, And A Lot Of Stocks Americans Ignore
24/7 Wall St

iShares Core MSCI EAFE ETF (IEFA) holds $169.6B in net assets with a 0.07% fee, tracking 2,590 developed-market holdings across Japan (24%), the United Kingdom (15%), France (9%), and Switzerland (9%), yielding 3.4% and delivering 19% returns over…

globes.co.il - Nitsan Shafir - Tech lawyers return to the fold
Tech lawyers return to the fold
גלובס

Several years ago, law firms reported a trend of lawyers leaving for other companies, taking on in-house legal positions within those companies, and even non-legal roles. The phenomenon was particularly common in tech companies but was also seen in…

marketbeat.com - Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
MarketBeat

Millennium Capital Advisors LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 11,875 shares…

marketbeat.com - AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
MarketBeat

WealthPlan Investment Management LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…

Receive a Daily briefing on Pharma Industry News

Get Started